EUVIMEDEUVIMED entdecken
Crossref

Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus

Liuchang He, Yunchao Wang, Hanghang Zhu, Kaihao Han, Sen Wei, Tao Quan, Panxing Li, Bo Yang, Ke Sun, Yazhou Jin, Anran Wang, Xinli Xue und 4 weitere

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2024.09.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Liuchang He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; NHC Key Laboratory of Prevention and Treatme…. Hauptthemen laut MEDLINE: Proteomics, Intracranial Thrombosis, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: First Affiliated Hospital of Zhengzhou University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute large vessel occlusion (LVO) stroke is highly prevalent and severe. Despite thrombolytic therapy, many patients experience substantial complications. Understanding the origins, constituents, and pathologic processes involved in thrombus formation in acute intracranial large artery occlusion is crucial. OBJECTIVES: To identify the characteristics of insoluble proteins from different sources of cerebral thrombus. METHODS: This study included 13 patients with cardiogenic embolic (CE) thrombus and 15 with large artery atherosclerotic (LAA) thrombus. High-performance liquid chromatography and liquid chromatography-tandem mass spectrometry were used to analyze insoluble proteins in thrombi. Bioinformatics analyses explored differential proteins and associated functional pathways. Least absolute shrinkage and selection operator and random forest identified biomarkers for diagnosing thrombus sources, validated by parallel reaction monitoring. RESULTS: We constructed an insoluble protein atlas of cerebral thrombi, identifying 6975 insoluble proteins, including 143 extracellular matrix (ECM)-related proteins. The enrichment pathways considerably varied between thrombi from different sources. Inflammation-related pathways, such as acute inflammatory response, along with ECM-related pathways such as laminin interactions, were notably upregulated in LAA compared with CE. Additionally, 2 biomarkers (IDH2 and HSPG2) exhibited strong diagnostic performance (area under the curve = 1) and robustness. CONCLUSION: In the insoluble proteomics of thrombus, we highlighted the crucial roles of immune responses and ECM proteins in thrombus formation, providing new insights into its mechanisms and potential drug development. Additionally, we identified 2 biomarkers that offer new methods for determining thrombus sources in patients with LVO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsIntracranial ThrombosisThrombosisHumansMaleFemaleMiddle AgedBiomarkersAgedTandem Mass SpectrometryComputational BiologyChromatography, High Pressure LiquidAcute Disease

Stichwörter der Autor:innen

extracellular matrixproteomicsthromboinflammationthrombosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou, Henan, China.
  • Department of Neurointerventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • The Neurology Intensive Care Unit, Jiaozuo Second People's Hospital, Jiaozuo, Henan, China.
  • Department of Neurology, Anyang People's Hospital, Anyang, Henan, China.
  • Clinical Systems Biology Laboratories, Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; NHC Key Laboratory of Prevention and Treatment of Cerebrovascular Diseases, Zhengzhou, Henan, China. Electronic ad…

Förderung

  • First Affiliated Hospital of Zhengzhou University
  • National Natural Science Foundation of China

Zitieren

APA

He, L., Wang, Y., Zhu, H., Han, K., Wei, S., Quan, T., Li, P., Yang, B., Sun, K., Jin, Y., Wang, A., Xue, X., Zhang, L., Liu, C., Gao, Y., & Xu, Y. (2025). Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.09.033

Vancouver

He L, Wang Y, Zhu H, Han K, Wei S, Quan T, et al. Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.09.033

BibTeX
@article{He2025,
  author = {He, Liuchang and Wang, Yunchao and Zhu, Hanghang and Han, Kaihao and Wei, Sen and Quan, Tao and Li, Panxing and Yang, Bo and Sun, Ke and Jin, Yazhou and Wang, Anran and Xue, Xinli and Zhang, Lei and Liu, Conghui and Gao, Yuan and Xu, Yuming},
  title = {Insoluble proteomics analysis of acute intracranial large vessel occlusive thrombus},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2024.09.033}
}
Kostenlos starten →